The automated counting of spots for the ELISpot assay.

[1]  G. Shaw,et al.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.

[2]  R. Royall.  Model robust confidence intervals using maximum likelihood estimators , 1986 .

[3]  Michael G Hudgens,et al.  Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials. , 2004, Journal of immunological methods.

[4]  P. McCullagh,et al.  Generalized Linear Models , 1992 .

[5]  M A Nowak,et al.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.

[6]  M. McElrath,et al.  Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. , 1997, The New England journal of medicine.

[7]  J. Leo van Hemmen,et al.  Temporal association , 1991 .

[8]  Yiming Shao,et al.  Enhanced: The Need for a Global HIV Vaccine Enterprise , 2003, Science.

[9]  J. Franklin,et al.  The elements of statistical learning: data mining, inference and prediction , 2005 .

[10]  M. Emerman,et al.  Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. , 1999, The Journal of infectious diseases.

[11]  M. Clerici,et al.  HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals , 1997, Nature Medicine.

[12]  S. Rowland-Jones,et al.  HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women , 1995, Nature Medicine.

[13]  D. Ho,et al.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.

[14]  Lewicki,et al.  Virus-Specific CD 8 + Cytotoxic T-Lymphocyte Activity Associated with Control of Viremia in Primary Human Immunodeficiency Virus Type 1 Infection , 2022 .

[15]  T. Matano.  HIV vaccine , 2005, Nihon rinsho. Japanese journal of clinical medicine.